Clincosm LogoSign in Get a demo

Psoriasis

Showing 51 - 75 of 951
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriasis Trial in Worldwide (Stelara, AVT04)

Completed
  • Psoriasis
  • Tallinn, Estonia
  • +29 more
Feb 1, 2023

Advanced Malignant Solid Tumor, Autoimmune Disease, Crohn Disease Trial in Canada, United States (Nivolumab)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +15 more
  • Biospecimen Collection
  • Nivolumab
  • Birmingham, Alabama
  • +46 more
Jan 31, 2023

Psoriasis Trial in Turkey (GN037, Clobetasol 17-Propionate Cream, Placebo)

Recruiting
  • Psoriasis
  • Ankara, Turkey
  • +11 more
Jan 23, 2023

Asking People With Psoriasis About Lifestyle and Eating

Recruiting
  • Psoriasis
    • London, United Kingdom
      King's College London
    Jan 27, 2023

    Psoriasis Trial in Barcelona, Granada, Pontevedra (Brodalumab, Ustekinumab, Placebo)

    Recruiting
    • Psoriasis
    • Brussels, Bruxelles-Capitale, Belgium
    • +21 more
    Jan 27, 2023

    Effect of Long-term Psoriasis on Patients' Life - CORONATE

    Recruiting
    • Psoriasis
      • Genoa, Genova, Italy
      • +15 more
      Jan 27, 2023

      The Psoriasis, Atherosclerosis, and Cardiometabolic Disease

      Active, not recruiting
      • Metabolic Disease
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2023

        Psoriasis Trial in United States (Deucravacitinib, Placebo)

        Not yet recruiting
        • Psoriasis
        • Phoenix, Arizona
        • +24 more
        Jan 26, 2023

        Psoriasis Trial in Worldwide (Risankizumab)

        Enrolling by invitation
        • Psoriasis
        • Fountain Valley, California
        • +36 more
        Jan 24, 2023

        Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa Trial in Canada, Germany, United States

        Recruiting
        • Atopic Dermatitis
        • +5 more
          • Scottsdale, Arizona
          • +61 more
          Jan 24, 2023

          Chronic Inflammation on Myocardial Perfusion and Function

          Completed
          • Psoriasis
          • 13N Amonia
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 24, 2023

          Psoriasis Trial in Beijing (IBI112 dose 2, IBI112 dose 4, IBI112 dose 1)

          Active, not recruiting
          • Psoriasis
          • IBI112 dose 2
          • +4 more
          • Beijing, Beijing, China
            PeKing University People's Hostpital
          Jan 20, 2023

          Psoriasis Trial in Canada, United States (VTX958, Placebo)

          Recruiting
          • Psoriasis
          • Hot Springs, Arkansas
          • +6 more
          Jan 19, 2023

          Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema Trial in Aurora (Tofacitinib)

          Recruiting
          • Down Syndrome
          • +5 more
          • Aurora, Colorado
            Linda Crnic Institute for Down Syndrome
          Jan 17, 2023

          Psoriasis Trial in France, Germany (Guselkumab, Placebo Injection)

          Active, not recruiting
          • Psoriasis
          • Antony, France
          • +89 more
          Jan 17, 2023

          Psoriasis Trial in Worldwide (Guselkumab)

          Recruiting
          • Psoriasis
          • Frankfurt, Germany
          • +7 more
          Jan 17, 2023

          Psoriasis Trial (Roflumilast, Methotrexate)

          Not yet recruiting
          • Psoriasis
          • (no location specified)
          Jan 5, 2023

          Psoriasis Trial in Ghent (biological, procedure, other)

          Completed
          • Psoriasis
          • Dose tapering of adalimumab in patients with supratheurapeutic serum trough levels
          • +4 more
          • Ghent, Belgium
            University Hospital
          Jan 5, 2023

          Plaque Psoriasis, Psoriasis Vulgaris, Psoriasis Trial in Worldwide (Brodalumab, Placebo, Guselkumab)

          Completed
          • Plaque Psoriasis
          • +2 more
          • Brodalumab
          • +2 more
          • Wien, Austria
          • +52 more
          Jan 11, 2023

          Psoriasis Trial in Canada, United States (Apremilast, Placebo)

          Completed
          Has Results
          • Psoriasis
          • Birmingham, Alabama
          • +63 more
          Jan 9, 2023

          Psoriasis Trial in United States (VTAMA® (tapinarof) Cream 1%)

          Recruiting
          • Psoriasis
          • VTAMA® (tapinarof) Cream 1%
          • Fort Smith, Arkansas
          • +6 more
          Jan 10, 2023

          Immune-mediated Diseases

          Recruiting
          • Primary Immunodeficiency
          • +3 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 10, 2023

            Rheumatoid Arthritis, Ankylosing Spondylitis, Fibromyalgia Trial in Upper Nyack

            Recruiting
            • Rheumatoid Arthritis
            • +12 more
              • Upper Nyack, New York
                Global Healthy Living Foundation
              Dec 23, 2022

              Psoriasis, Alopecia Areata, Polymorphous Light Eruption Trial (Lumiton yarn sleeve, Lumiton yarn hat, Lumiton yarn shirt)

              Recruiting
              • Psoriasis
              • +2 more
              • Lumiton yarn sleeve
              • +2 more
              • Winston-Salem, North Carolina
                Wake Forest University Health Sciences, Dermatology
              Dec 21, 2022

              Psoriasis Trial in Worldwide (Apremilast, Placebo)

              Completed
              Has Results
              • Psoriasis
              • Birmingham, Alabama
              • +51 more
              Nov 17, 2022